Molecular
Insight Pharmaceuticals Inc (NASDAQ:MIPI) will hold a conference call on
Friday, March 31 at 10:00 am to discuss the fourth quarter and year end
earnings for 2007.
A
biopharmaceutical company, Molecular Insight Pharmaceuticals is engaged in the
discovery, development and commercialization of targeted radio therapeutics and
molecular imaging pharmaceuticals with applications in the oncology and
cardiology areas.
With two
clinical stage radio therapeutic product candidates, the company has identified
other potential candidates for the detection and treatment of prostate cancer,
heart failure and neurodegenerative disease.
Azedra is in an orphan drug status and a fast track designation by the
United States Food and Drug Administration (FDA). Onalta is the other clinical stage radio
therapeutic candidate. Zemiva is a
clinical stage molecular imaging pharmaceutical product candidate.
Molecular
Insight Pharmaceuticals Inc (NASDAQ:MIPI)
For more
Conference Call related events or to post your own events, visit:
http://events.finditt.com/Events_List.aspx?catid=12
